Logo-ipp

Original

1. Evaluation of the feasibility of using weekly paclitaxel as neoadjuvant therapy in patients with epithelial ovarian cancer; a pre-post clinical trial
Sakineh Ebrahimi ORCID, Seyed Saeed Hashemi Nazari ORCID, Arash Dooghaie Moghadam ORCID, Shirin Haghighi* ORCID
Immunopathol Persa. 2021;7(1): e09. doi: 10.34172/ipp.2021.09
Scopus ID: 85105074111    
Article
PDF
XML
Cited By:
1
1
Review

2. Impact of analgesics on the risk of ovarian cancer; a systematic review and meta-analysis of cohort and case-control studies
Javad Sadeghi ORCID, Saba Bazzazi ORCID, Farinaz Fattahi ORCID, Moloud Alsadat Mousavi ORCID, Ardeshir Tajbakhsh ORCID, Sadaf Rassouli ORCID, Siavash Sangi ORCID, Mahshad Ghezelbash ORCID, Anna Ghorbani* ORCID
Immunopathol Persa. 2025;. doi: 10.34172/ipp.2023.40572
Article
PDF
XML
Cited By:
0